Journal article
ANTI-INTERLEUKIN-12 THERAPY PROTECTS MICE IN LETHAL ENDOTOXEMIA BUT IMPAIRS BACTERIAL CLEARANCE IN MURINE ESCHERICHIA COLI PERITONEAL SEPSIS
Abstract
The overzealous production of proinflammatory cytokines in sepsis can result in shock, multiorgan dysfunction, and even death. In this study we assessed the role of endogenously produced interleukin (IL)-12 in murine models of endotoxemia and Gram-negative peritoneal sepsis. Initial studies indicated that intraperitoneal lipopolysaccharide (LPS) administration to mice induced a significant time-dependent increase in plasma, lung, and liver …
Authors
Zisman DA; Kunkel SL; Strieter RM; Gauldie J; Tsai WC; Bramson J; Wilkowski JM; Bucknell KA; Standiford TJ
Journal
Shock, Vol. 8, No. 5, pp. 349–356
Publisher
Wolters Kluwer
Publication Date
11 1997
DOI
10.1097/00024382-199711000-00006
ISSN
1073-2322
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AnimalsAscitic FluidBacteremiaBase SequenceColony Count, MicrobialDNA PrimersDisease Models, AnimalEndotoxemiaEscherichia coliEscherichia coli InfectionsFemaleGene ExpressionImmunization, PassiveInterferon-gammaInterleukin-12Macrophages, AlveolarMicePeritonitisRNA, MessengerSepsisTumor Necrosis Factor-alpha